Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sagopilone in Recurrent Glioblastoma
NCT00424060Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Dec 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sagopilone in glioblastoma (GBM), sponsored by European Organisation for Research and Treatment of Cancer. Started Dec 2006; status: completed.
02
Drugs
sagopilone
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT00424060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00424060.